StoneX Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

StoneX Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,509	Closed	-$387K	–	520
2022 Q4	$387K	Sell	2,509 -2,217	-47%	-$327K	0.06%	262
2022 Q3	$624K	Buy	4,726 +1,775	+60%	+$249K	0.12%	136
2022 Q2	$400K	Sell	2,951 -532	-15%	-$73.3K	0.07%	203
2022 Q1	$519K	Sell	3,483 -1,545	-31%	-$229K	0.05%	306
2021 Q4	$825K	Buy	+5,028	New	+$813K	0.1%	203
2019 Q1	–	Sell	-6,131	Closed	-$761K	–	227
2018 Q4	$761K	Sell	6,131 -631	-9%	-$86.3K	0.73%	38
2018 Q3	$1.07M	Buy	+6,762	New	+$1.02M	0.8%	31
2016 Q4	–	Sell	-11,534	Closed	-$225K	–	80
2016 Q3	$225K	Buy	+11,534	New	+$1.13M	0.5%	64

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

StoneX Group's FBT Position: Q1 2023 in Review

StoneX Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2023, closing a stake of 2,509 shares — an estimated $387K sold.

StoneX Group first reported a position in FBT in Q3 2016 and held it in 8 quarters. The position peaked at $1.07M in Q3 2018. 245 funds tracked by Wall St. Rank hold FBT as of Q1 2023.

StoneX Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 2,509 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2023, an estimated $387K.
StoneX Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2016 and held it in 8 quarters.
StoneX Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.07M in Q3 2018.
245 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.